FRANCESCHINI, Erica
 Distribuzione geografica
Continente #
NA - Nord America 13.864
AS - Asia 6.532
EU - Europa 6.453
SA - Sud America 993
Continente sconosciuto - Info sul continente non disponibili 244
AF - Africa 174
OC - Oceania 22
AN - Antartide 1
Totale 28.283
Nazione #
US - Stati Uniti d'America 13.352
IT - Italia 2.439
SG - Singapore 1.928
CN - Cina 1.529
GB - Regno Unito 1.267
VN - Vietnam 792
HK - Hong Kong 709
BR - Brasile 701
DE - Germania 620
BD - Bangladesh 517
SE - Svezia 440
RU - Federazione Russa 342
CA - Canada 304
FI - Finlandia 296
FR - Francia 289
KR - Corea 205
ID - Indonesia 161
IN - India 148
NL - Olanda 147
TR - Turchia 107
AR - Argentina 100
UA - Ucraina 81
MX - Messico 78
ES - Italia 73
BG - Bulgaria 71
JP - Giappone 71
PL - Polonia 57
LT - Lituania 54
IQ - Iraq 51
CO - Colombia 45
ZA - Sudafrica 45
PK - Pakistan 40
AE - Emirati Arabi Uniti 38
IE - Irlanda 37
CZ - Repubblica Ceca 32
EC - Ecuador 32
AT - Austria 31
BE - Belgio 31
VE - Venezuela 30
CR - Costa Rica 29
SI - Slovenia 29
CL - Cile 28
MA - Marocco 28
MY - Malesia 21
CH - Svizzera 20
IL - Israele 20
PE - Perù 20
AU - Australia 19
IR - Iran 18
PY - Paraguay 18
UZ - Uzbekistan 18
EG - Egitto 17
NP - Nepal 17
SA - Arabia Saudita 17
SV - El Salvador 16
TH - Thailandia 16
PH - Filippine 15
JM - Giamaica 14
GT - Guatemala 13
JO - Giordania 12
TN - Tunisia 12
TW - Taiwan 12
KE - Kenya 11
RO - Romania 11
AZ - Azerbaigian 10
DZ - Algeria 10
GR - Grecia 10
PR - Porto Rico 10
BO - Bolivia 9
ET - Etiopia 9
KZ - Kazakistan 9
OM - Oman 9
SN - Senegal 9
TT - Trinidad e Tobago 9
PA - Panama 8
PT - Portogallo 8
DK - Danimarca 7
EE - Estonia 7
GE - Georgia 7
HN - Honduras 7
HU - Ungheria 7
LV - Lettonia 7
NG - Nigeria 7
PS - Palestinian Territory 7
UY - Uruguay 7
AL - Albania 6
DO - Repubblica Dominicana 6
SK - Slovacchia (Repubblica Slovacca) 6
MK - Macedonia 5
SC - Seychelles 5
BH - Bahrain 4
CI - Costa d'Avorio 4
CW - ???statistics.table.value.countryCode.CW??? 4
MN - Mongolia 4
NI - Nicaragua 4
NO - Norvegia 4
RS - Serbia 4
SD - Sudan 4
SY - Repubblica araba siriana 4
A2 - ???statistics.table.value.countryCode.A2??? 3
Totale 27.981
Città #
Ashburn 1.722
Santa Clara 1.218
Singapore 1.206
San Jose 928
Southend 768
Fairfield 734
Hong Kong 681
Chandler 575
Council Bluffs 514
Hefei 482
Houston 323
Seattle 319
Los Angeles 310
New York 290
Woodbridge 282
Nyköping 276
London 260
Beijing 245
Ho Chi Minh City 243
Dallas 237
Cambridge 236
Wilmington 230
Helsinki 219
Seoul 199
Milan 198
Chicago 197
Modena 185
Hanoi 173
Munich 162
Ann Arbor 151
Bologna 148
Rome 141
The Dalles 134
San Diego 124
Jakarta 122
Dearborn 98
Lauterbourg 98
Toronto 92
Shanghai 91
Buffalo 90
Moscow 80
Jacksonville 76
Atlanta 73
São Paulo 72
Boardman 65
Princeton 65
Sofia 60
Orem 59
Naples 58
Tokyo 58
Frankfurt am Main 55
Parma 55
Phoenix 51
Warsaw 50
Montreal 48
Salt Lake City 47
Bremen 46
Turku 45
Columbus 43
Amsterdam 42
Nuremberg 42
Izmir 40
Redwood City 40
Fremont 39
Da Nang 38
Reggio Emilia 38
North York 37
Haiphong 36
Brooklyn 34
Mexico City 34
Stockholm 32
Turin 32
Hillsboro 30
San Francisco 30
Johannesburg 28
Tampa 28
North Bergen 27
Palermo 27
Brussels 26
Denver 26
Dublin 26
Falls Church 26
Kent 26
Paris 26
Redondo Beach 26
Rimini 24
Catania 23
Chennai 23
Florence 23
Mumbai 23
Des Moines 22
Rio de Janeiro 22
Verona 22
Eugene 21
Miami 21
San José 21
Boston 20
Durham 20
Elk Grove Village 20
Guangzhou 20
Totale 16.968
Nome #
Multidrug-resistant tuberculosis outbreak in an Italian prison: Tolerance of pyrazinamide plus levofloxacin prophylaxis and serial interferon gamma release assays 822
Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality. 560
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 535
A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unit 496
Clinical Utility of Epstein-Barr Virus Viral Load Monitoring and Risk Factors for Posttransplant Lymphoproliferative Disorders After Kidney Transplantation 493
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 484
Clinical outcome of kidney transplantation in HIV-infected recipients: a retrospective study 455
Efficient T cell compartment in HIV+ patients receiving orthotopic liver transplant and immunosuppressive therapy 454
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection 449
A frailty index predicts post-liver transplant morbidity and mortality in HIV-positive patients 445
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 442
Metabolic reprograming shapes neutrophil functions in severe COVID-19 434
Two fatal cases of acute liver failure due to HSV-1 infection in COVID-19 patients following immunomodulatory therapies. 426
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. 414
Acute human herpes virus 7 (HHV-7) encephalitis in an immunocompetent adult patient: a case report and review of literature 409
Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia - challenges, strengths, and opportunities in a global health emergency. 406
Antimicrobial stewardship in a Gastroenterology Department: Impact on antimicrobial consumption, antimicrobial resistance and clinical outcome 395
Gastric Mucormycosis in a Liver and Kidney Transplant Recipient: Case Report and Concise Review of Literature 391
Herpes Simplex re-activation in patients with SARS-CoV2 pneumonia: a prospective observational study. 389
Risk factors for pulmonary air leak and clinical prognosis in patients with COVID-19 related acute respiratory failure: a retrospective matched control study. 384
Rhodococcus equi Pneumonia in Kidney Transplant Recipient Affected by Acute Intermittent Porphyria: A Case Report 383
Incidence, risk factors and outcome of acute kidney injury (AKI) in patients with COVID-19 374
Comparison of Patients With or Without COVID-19 and Without Hematological Diseases Treated for Invasive Pulmonary Aspergillosis: A 5-Year Retrospective Cohort Study with Propensity-Based Adjustment 364
Immunophenotypic Profile and Clinical Outcome of Monoclonal B-cell Lymphocytosis in Kidney Transplantation 353
First and second waves among hospitalised patients with COVID-19 with severe pneumonia: a comparison of 28-day mortality over the 1-year pandemic in a tertiary university hospital in Italy 353
Hypokalemia in Patients with COVID-19 352
Darunavir/Cobicistat Is Associated with Negative Outcomes in HIV-Negative Patients with Severe COVID-19 Pneumonia 351
INTRAVENOUS FOSFOMYCIN IN COMBINATION REGIMENS AS A TREATMENT OPTION FOR DIFFICULT-TO-TREAT INFECTIONS DUE TO MULTIDRUG-RESISTANT GRAM-NEGATIVE ORGANISMS: A REAL-LIFE EXPERIENCE 345
Clinical and Microbiological Characteristics of Visceral Leishmaniasis Outbreak in a Northern Italian Nonendemic Area: A Retrospective Observational Study 341
The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study 321
Peritoneal dialysis in the time of coronavirus disease 2019 317
Should we screen for NAFLD/NASH in HIV patients? 312
Aseptic Osteonecrosis: A Newly Diagnosed Complication in HIV-Infected Patients Undergoing Liver Transplantation. 303
Changing in the post-surgery infective complications following the shortening of the antibiotic prophylaxis in the patients undergoing skin dermal substitutes reconstruction 303
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 297
A Fatal Case of Pseudomonas aeruginosa Community-Acquired Pneumonia in an Immunocompetent Patient: Clinical and Molecular Characterization and Literature Review 296
Characteristics of HIV-infected patients not retained in care of two cohorts of northern Italy. 294
Antiviral activity of sirolimus in an HIV-positive kidney transplant recipient 293
Acid base disorders in patients with COVID-19 293
Advances and Challenges in Sepsis Management: Modern Tools and Future Directions 287
Epidemiology and Outcomes of Bloodstream Infections in HIV-Patients during a 13-Year Period 286
Immunomodulation for the management of severe SARS-CoV2 infections. State of the art and review of the literature 283
Infective complications in patients undergoing surgical reconstruction with dermal matrix: the Modena experience 279
Engagement and retention in care of patients diagnosed with HIV infection and enrolled in the Modena HIV surveillance cohort. 276
Not just minor resections: robotic approach for cystic echinococcosis of the liver 272
Epidemiology and Risk Factors Associated with Mortality in Consecutive Patients with Bacterial Bloodstream Infection: Impact of MDR and XDR Bacteria 270
Seven versus fourteen Days of Antibiotic Therapy for uncomplicated Gram-negative Bacteremia: a Non-inferiority Randomized Controlled Trial 269
Pneumocystosis as a Complication of H1N1 Influenza A Infection in an HIV-Positive Patient on Effective cART 264
Long-Term Suppressive Therapeutic-Drug-Monitoring-Guided Dalbavancin Therapy for Cardiovascular Prosthetic Infections 263
A proof-of-concept study on the genomic evolution of Sars-Cov-2 in molnupiravir-treated, paxlovid-treated and drug-naïve patients 259
Ceftazidime/Avibactam in Ventilator-Associated Pneumonia Due to Difficult-to-Treat Non-Fermenter Gram-Negative Bacteria in COVID-19 Patients: A Case Series and Review of the Literature 258
Risk factors for nosocomial rectal colonization with carbapenem-resistant Acinetobacter baumannii in hospital: a matched case–control study 246
Long-Term Impact of the COVID-19 Pandemic on In-Hospital Antibiotic Consumption and Antibiotic Resistance: A Time Series Analysis (2015-2021) 244
Comparison of two perioperative antibiotic schedules in patients undergoing surgical reconstruction with dermal matrix after excision of skin cancer 243
Awaiting a cure for COVID-19: therapeutic approach in patients with different severity levels of COVID-19 235
Is It Possible to Eradicate Carbapenem-Resistant Acinetobacter baumannii (CRAB) from Endemic Hospitals? 234
Death After Liver Transplantation: Mining Interpretable Risk Factors for Survival Prediction 233
Central Nervous System Infections Caused by Bacillus Calmette-Guerin: Case Report and Narrative Literature Review 232
Pneumocystis jirovecii pneumonia in patients with decompensated cirrhosis: a case series 230
Development of post-COVID-19 cardiovascular events: An analysis of clinical features and risk factors from a single hospital retrospective study 229
Blackwater Fever Treated with Steroids in Nonimmune Patient, Italy 227
Association Between Pulmonary Aspergillosis And Cytomegalovirus Reactivation In Critically Ill Covid-19 Patients: A Prospective Observational Cohort Study. 226
Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort Study 224
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: a prospective multicentre study 224
Real-life experience with compassionate use of cefiderocol for difficult-to-treat resistant Pseudomonas aeruginosa (DTR-P) infections 217
Carbapenemase type and mortality in blood-stream infections caused by carbapenemase-producing enterobacterales: a multicenter retrospective cohort study 213
AKI in hospitalized patients with COVID-19: a single-center experience 206
Development of a Risk Prediction Model for Carbapenem-resistant Enterobacteriaceae Infection after Liver Transplantation: A Multinational Cohort Study 205
Prospective Study on Incidence, Risk Factors and Outcome of Recurrent Clostridioides difficile Infections 203
Severe acute respiratory syndrome coronavirus 2 infection in patients with hematological malignancies in the Omicron era: Respiratory failure, need for mechanical ventilation and mortality in seronegative and seropositive patients 200
External Validity of a Randomized Controlled Trial on Duration of Antibiotics for the Treatment of Gram-Negative Bacteremia 197
Prolonged RT-PCR test positivity in hemodialysis patients with COVID-19 193
The WEST Study: A Retrospective and Multicentric Study on the Impact of Steroid Therapy in West Nile Encephalitis 190
A rare case of necrotizing fasciitis of the leg in an intravenous drug user caused by Prevotella denticola 189
Low-molecular-weight heparin for the prevention of clinical worsening in severe non-critically ill COVID-19 patients: a joint analysis of two randomized controlled trials 189
Perioperative Use of IgM-Enriched Immunoglobulins in Liver Transplantation Recipients at High Risk for Infections: A Preliminary Study 187
Epidemiology and Prevention of Early Infections by Multi-Drug-Resistant Organisms in Adults Undergoing Liver Transplant: A Narrative Review 183
Impact of VRE-active perioperative prophylaxis in liver transplant patients colonized by Vancomycin-Resistant Enterococci 181
Role of Maraviroc in minimizing the risk of graft rejection in HIV-infected kidney transplant recipients 179
Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients 176
Molecular and cellular immune features of aged patients with severe COVID-19 pneumonia 175
A Desirability of Outcome Ranking Analysis of a Randomized Clinical Trial Comparing Seven Versus Fourteen Days of Antibiotics for Uncomplicated Gram-Negative Bloodstream Infection 174
COVID-19 omicron variant outbreak in a hematopoietic stem cell transplant unit 173
Risk factors for functional decline among survivors of Gram-negative bloodstream infection: A prospective cohort study 171
Reactogenicity of COVID-19 vaccine in hemodialysis patients: a single-center retrospective study 159
Duration of antibiotic treatment for Gram-negative bacteremia - Systematic review and individual participant data (IPD) meta-analysis 158
Efficacy of bezlotoxumab in preventing recurrence of Clostridioides difficile infection: an Italian multicenter cohort study 154
Vancomycin resistant enterococcus risk factors for hospital colonization in hematological patients: a matched case-control study 153
First Human Case of Tick-Borne Encephalitis in Non-Endemic Region in Italy: A Case Report 150
Monotherapy vs combination therapy for Enterococcus faecalis bacteremia: a target trial emulation 150
Use of colistin in adult patients: A cross-sectional study 149
The Impact of COVID-19 on UNAIDS 90-90-90 Targets: Calls for New HIV Care Models 144
Concomitant Autoimmune Liver Disease and Hepatic Actinomycosis: A Diagnostic Challenge—Brief Report and Review of the Literature 143
Persistent SARS-CoV-2 infection with multiple clinical relapses in two patients with follicular lymphoma treated with bendamustine and obinutuzumab or rituximab 143
Distinct leishmania infantum strains circulate in humans and dogs in the Emilia-Romagna region, northeastern Italy 142
Development and validation of a prediction score for failure to casirivimab/imdevimab in hospitalized patients with COVID-19 pneumonia 122
Serological and molecular tools to diagnose visceral leishmaniasis: 2-years’ experience of a single center in Northern Italy 110
Streptococcus pneumoniae bacteremia: comparison of incidence, epidemiology, and clinical outcome in a pre- and post-COVID-19 period 104
Clinical utility of the DENOVA score for predicting infective endocarditis in Enterococcus faecalis bacteraemia: external validation with decision curve analysis 98
Impact of vancomycin resistance on attributable mortality among Enterococcus faecium bloodstream infections: propensity score analysis of a large, multicentre retrospective study 89
Totale 27.790
Categoria #
all - tutte 111.783
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.783


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.449 0 0 0 79 87 100 205 103 185 146 323 221
2022/20231.969 235 259 176 185 216 244 66 162 187 38 93 108
2023/20241.720 60 93 133 167 295 195 116 178 64 65 130 224
2024/20254.862 144 97 111 323 812 743 415 291 586 235 496 609
2025/202610.325 714 438 783 1.086 1.385 592 1.226 516 981 1.078 882 644
2026/20273.798 530 1.553 651 1.064 0 0 0 0 0 0 0 0
Totale 28.283